| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 13576 |
| 1 | PREDNISONE | 10864 |
| 2 | DUPILUMAB | 10724 |
| 3 | METHOTREXATE SODIUM | 10566 |
| 4 | POLYETHYLENE GLYCOL 3350 | 10036 |
| 5 | ACETAMINOPHEN | 9489 |
| 6 | METHOTREXATE | 9460 |
| 7 | DICLOFENAC SODIUM | 9403 |
| 8 | ADALIMUMAB | 7605 |
| 9 | CETIRIZINE HYDROCHLORIDE | 7584 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 6332 | 0.5028 |
| 1 | INFLIXIMAB-DYYB | 1198 | 0.3476 |
| 2 | PSEUDOEPHEDRINE HCL | 3450 | 0.3152 |
| 3 | CORTISONE ACETATE | 3608 | 0.2886 |
| 4 | DESOXIMETASONE | 4535 | 0.2353 |
| 5 | ERGOCALCIFEROL | 6264 | 0.2107 |
| 6 | TOFACITINIB CITRATE | 2218 | 0.1655 |
| 7 | DICLOFENAC POTASSIUM TABLETS | 1384 | 0.1596 |
| 8 | CETIRIZINE HYDROCHLORIDE TABLETS | 4693 | 0.1496 |
| 9 | DICLOFENAC POTASSIUM | 1486 | 0.1344 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 19774 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 18996 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17108 |
| 3 | Osmotic Laxative [EPC] | 12058 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 10724 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 9551 |
| 6 | Vitamin C [EPC] | 9257 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 7894 |
| 8 | Vitamin B12 [EPC] | 7882 |
| 9 | Benzodiazepine [EPC] | 7522 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 844 | 1.2267 |
| 1 | Provitamin D2 Compound [EPC] | 6264 | 0.2105 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 315 | 0.1518 |
| 3 | Semifluorinated Alkane [EPC] | 240 | 0.1032 |
| 4 | Interleukin-17A Antagonist [EPC] | 3783 | 0.1015 |
| 5 | Endoglycosidase [EPC] | 168 | 0.0907 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 204 | 0.0851 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 490 | 0.0837 |
| 8 | Ectoparasiticide [EPC] | 315 | 0.0804 |
| 9 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 163 | 0.0718 |